Elsevier

Matrix

Volume 11, Issue 1, February 1991, Pages 17-24
Matrix

Effect of Interleukin-1 and Insulin Like Growth Factor-1 on the Release of Proteoglycan Components and Hyaluronan from Pig Articular Cartilage in Explant Culture

https://doi.org/10.1016/S0934-8832(11)80223-4Get rights and content

Abstract

The turnover of proteoglycans was investigated in articular cartilage in explant culture by analysing the components released into the culture medium. The effect of IL-1± on the release of fragments derived from different proteoglycan domains and of hyaluronan (HA) was determined over 4 days in culture. The effect of IGF-1 (100 ng/ml) on matrix degradation of proteoglycan and its ability to inhibit the effects of IL-1 (10 ng/ml) was also assessed. The rate of release of G1 and G2 globular domains of proteoglycans into the culture medium was determined by radioimmunoassay.

In unstimulated control cartilage there was a greater release of proteoglycan G2 domain than of G1 domain suggesting that cleavage occured between them and that some G1 was preferentially retained bound in the matrix. Compared with control cartilage IL-1 stimulated the release of all proteoglycan components and hyaluronan. IL-1 had a greater effect on the release of G1 than on G2 domain, but also resulted in some net loss of these proteins (∼ 45% as detected in the immunoassays). In explants treated with both IL-1 and IGF-1 there was much less release of proteoglycan fragments and evidence for less extensive degradation. IGF-1 was particularly affective in preventing any increase in HA release and also preventing the apparent loss of G 1 and G2 domains. It also partially inhibited the release of G1 and G2 domains and the sulphated glycosaminoglycan fragments. IGF-1 was therefore an effective antagonist of IL-1 action on cartilage. It is not known at what level it blocks the chondrocyte response to IL-1, but it clearly results in the suppression of matrix degradative activity.

References (34)

  • J. Saus et al.

    The complete primary structure of human matrix metalloproteinase-3

    Identity with stromelysin. J. Biol. Chem.

    (1988)
  • F. Bonnet et al.

    Structure and interactions of cartilage proteoglycan binding region and link proteins

    Biochem. J.

    (1985)
  • G. Fairbanks et al.

    Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane

    Biochemistry

    (1971)
  • R.W. Farndale et al.

    A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures

    Connect. Tissue Res.

    (1982)
  • A.J. Fosang et al.

    Isolation of the N-terminal globular protein domains from cartilage proteoglycans

    Identification of G2 domain and its lack of interaction with hyaluronate and link protein. Biochem. J.

    (1989)
  • S.M. Frish et al.

    Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone

    J. Biol. Chem.

    (1987)
  • H.L. Guenther et al.

    Effect of insulin-like growth factor on collagen and glycosaminoglycan synthesis by rabbit articular chondrocytes in culture

    Experentia

    (1982)
  • Cited by (94)

    • Biology of Proteoglycans and Associated Glycosaminoglycans

      2021, Comprehensive Glycoscience: Second Edition
    • The pericellular hyaluronan of articular chondrocytes

      2019, Matrix Biology
      Citation Excerpt :

      In some studies, HA turnover occurs in close proportion to the turnover of aggrecan [6,38–43] whereas in others, HA turnover is greater than [43,44] or less than [36] the turnover of aggrecan. In some cases, large amounts of partially-degraded HA are released from cartilage [39–41] and others, as noted above, only a small fraction is released [35,37]. How can we make sense of these patterns?

    • Cellular and molecular mechanisms of cartilage damage and repair

      2014, Drug Discovery Today
      Citation Excerpt :

      Some of these discrepancies can be explained by focal production of inflammatory cytokines but also by temporal dynamics: episodes of inflammation that can be short-lived but can lead to accruing damage. Functionally, IL-1 treatment induces intense aggrecanolysis [30] and upregulates cartilage-degrading enzymes such as MMPs [31] and ADAMTS-4 and/or -5 expression [32]. IL-1β can also suppress the synthesis of the cartilage ECM components [33].

    View all citing articles on Scopus
    a

    Present address: Dept. of Medicine, University of Melbourne Royal Melbourne Hospital, Parkville, Victoria, Australia

    b

    Dr. T. E. Hardingham, Head, Biochemistry Division, Kennedy Institute of Rheumatology, 6 Bute Gardens, Hammersmith, London W6 7DW, UK.

    View full text